Gauddi Therapeutics harnesses deep machine learning and AI modeling techniques to create breakthrough RNA-modifying engagers (RMEs) for patients with high unmet clinical needs. The Gauddi Therapeutics drug discovery engine is specifically designed to focus on targeted protein-protein interaction at the posttranscriptional level. Gauddi targets play pivotal roles in autoimmune disease, and our unique AI-guided strategy sets us apart in providing game-changing therapies for patients.